News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Genomics Company NimbleGen Systems, Inc. Raises $8.2 Million In Late Stage Round
December 6, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NimbleGen Systems Inc., a genomic analysis company, said that it has raised another $8.2 million in its Series F round of financing.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Pipeline
AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolio
April 30, 2026
·
2 min read
·
Tristan Manalac
Insights
What makes life science angel investment work?
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
Earnings
AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate
April 29, 2026
·
3 min read
·
Gabrielle Masson
